CLU and Parkinson disease: Exosomal clusterin was significantly decreased in PD patients with Hoehn and Yahr stages II (by 1.5- to 1.8-fold) and III (by 1.8- to 2.0-fold) as compared to healthy individuals but was not listed among plasma proteins significantly different between PD patients and healthy controls.